A

Allogene Therapeutics, Inc. (ALLO)

NMS – Цена в реальном времени. Валюта: USD

2.07

-0.05 (-2.36%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

2.07

0.00 (0.00%)

После закрытия: Aug 12, 2026, 4:04 PM EDT

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

A

Allogene Therapeutics, Inc. (ALLO)

NMS – Цена в реальном времени. Валюта: USD

2.07

-0.05 (-2.36%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

2.07

0.00 (0.00%)

После закрытия: Aug 12, 2026, 4:04 PM EDT

04.08.2026

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced that it will report second quarter 2026 financial results and provide a business update on August 12, 2026, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET.

Видео

No Data

There is no data to display

Search stocks

Allogene Therapeutics, Inc. (ALLO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Видео

No Data